Recombinant E.coli CM1 Protein，His

PTK2, also known as focal adhesion kinase (FAK), is a non-receptor tyrosine kinase that plays a crucial role in various cellular processes, including cell adhesion, migration, and survival. The study of PTK2 has gained significant attention due to its involvement in various diseases, particularly cancer, where it is often upregulated and contributes to tumor progression and metastasis. The mechanism of PTK2 activation and its downstream signaling pathways are essential for understanding how cells respond to external stimuli and interact with their microenvironment. Research into the recombinant expression of PTK2 allows scientists to produce large quantities of the protein for structural and functional studies, facilitating the elucidation of its biological roles. Understanding the structure of PTK2 through crystallography and other biophysical methods can provide insights into its function and regulation. Additionally, exploring PTK2's interactions with other signaling molecules is vital for identifying potential therapeutic targets. Given its significance in disease progression, PTK2 is a promising candidate for drug development, making the study of its recombinant protein particularly relevant for developing strategies to combat cancer and other diseases linked to dysregulated cell signaling. Overall, the research on PTK2 recombinant protein not only deepens our understanding of fundamental cellular processes but also holds potential for advancing therapeutic interventions.